Matthew Bertelson

Pillar Biosciences Closes $29.7 Million in Series C Financing

Financing to Advance IVD and RUO Product Development and to Expand Global Commercialization Natick, MA, May 5, 2020—Pillar Biosciences, an NGS clinical cancer diagnostics company, today announced the closing of a $29.7 million Series C preferred stock financing. The financing will accelerate the expansion of Pillar’s in vitro diagnostic and research use only panels and …

Pillar Biosciences Closes $29.7 Million in Series C Financing Read More »

Social media graphic stating that Pillar Biosciences at MedLab Middle East 2020. Background image shows the Dubai skyline at night.

Pillar at MedLab Middle East 2020

Join us at the MedLab Middle East 2020 Exhibition, where we will showcase the diversity and flexibility of Pillar’s NGS platform across platforms, mutation types and panel designs. Visit us at booth Z3 C36 in the American Pavilion. About Pillar Biosciences Research Panels Research-use-only (RUO) panels sold by Pillar (including the ONCO/Reveal Solid Tumor Panel) are …

Pillar at MedLab Middle East 2020 Read More »

a graphic that reads "Garbage in, Greatness out" next to a photo of a tumor sample embedded in parafin wax for analysis

Garbage in, greatness out: making the most of FFPE samples

The cancer research community relies on formalin-fixed samples, but the quality of these samples degrades over time. Sequencing data from partially degraded samples is plagued with artifacts. To address this “garbage in, garbage out” problem, Pillar Biosciences has developed a suite of tools that help sort actual variants from artifactual variants in low quality samples. …

Garbage in, greatness out: making the most of FFPE samples Read More »

Social media graphic stating that Pillar Biosciences at MedLab Middle East 2020. Background image shows the Dubai skyline at night.

Join Pillar Biosciences at AACR 2019

Pillar Biosciences at AACR 2019   Pillar Biosciences is exhibiting at The American Association for Cancer Research (AACR) Annual Meeting in Atlanta, Georgia. Stop by booth 3254 to learn about the latest advancements in custom NGS assay development and precision medicine at this important annual cancer research conference. Learn more

Join Pillar Biosciences at the Association for Biomolecular Research Facilities Annual Meeting 2019

Technology Showcase Presentation: Making Precision Medicine Accessible with SLIMamp®:Robust, Rapid, Single-Tube Multiplex NGS Panels On Sunday, March 24 at 6:30pm, Martin Zillmann, Ph.D., Chief Operating Officer at Pillar Biosciences, discussed Pillar’s proprietary NGS technology and approach to the detection of low allele frequency mutations from low DNA inputs. Poster presentation: “ampPD – An Automated Primer …

Join Pillar Biosciences at the Association for Biomolecular Research Facilities Annual Meeting 2019 Read More »

Social media graphic advertising the AMP 2018 Pillar Workshop speaker, Helen Fernandes, PhD.

Workshop: Single-vial amplification-based NGS to interrogate variants in tumors with limited diagnostic material

Helen Fernandes, PhD, Co-director of Genomic Oncology at Columbia University, presented a talk on October 31, 2018 during the Corporate Workshop Day at the 2018 Association for Molecular Pathology (AMP) Annual Meeting in San Antonio, Texas.  Click below to watch Dr. Fernandes’ talk:   Click here In her talk, titled “Single-vial amplification-based NGS with rapid …

Workshop: Single-vial amplification-based NGS to interrogate variants in tumors with limited diagnostic material Read More »

WP Feedback

Dive straight into the feedback!
Login below and you can start commenting using your own user instantly

Scroll to Top